No Data
No Data
No Data
No Data
No Data
Appili Therapeutics Announces Additional Bridge Loan From Bloom Burton & Co.
Yahoo FinanceApr 27 07:03
Aditxt Signs Agreement to Acquire Appili Therapeutics
Seeking AlphaApr 2 20:51
Appili Therapeutics Reports Q3 Results
Seeking AlphaFeb 14 21:37
Appili Therapeutics Says Patent Issued For Biodefence Vaccine Candidate ATI-1701, Provides Update on Bridge Loan
Appili Therapeutics Inc. (APLI.TO) on Friday said the United States Patent and Trademark Office (USPTO) has published patent claims for ATI-1701. The patent covers the composition and preparation methods for the vaccine through 2039.
MT NewswiresDec 15, 2023 21:18
Appili Therapeutics Announces U.S. FDA Approval of LIKMEZ (ATI-1501) Metronidazole Oral Suspension
FDA approves LIKMEZ as the brand name for Metronidazole Oral Suspension (LIKMEZ is a Trademark of Saptalis Pharmaceuticals, LLC) Currently LIKMEZ is the only liquid oral suspension of metronidazole approved in the
BusinesswireSep 25, 2023 19:54
Appili Therapeutics GAAP EPS of -C$0.01
Seeking AlphaAug 12, 2023 05:45
No Data
No Data